Abstract
Rationale: Exclusive enteral nutrition (EEN) is the primary first line treatment to achieve disease remission in paediatric Crohn’s disease (CD) in New Zealand (NZ). The aim of this study was to identify paediatric patients in Auckland diagnosed with CD at Starship Child Health and investigate clinical outcomes of EEN use at diagnosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
